Atrial arrhythmias were found in 26% of patients with sickle cell disease (SCD), with a significant association with stroke history. Early detection and treatment of atrial arrhythmias may help ...

Christopher Michaeles, MD, FACC, joined by the practice’s latest addition, Dr. Haneen Ismail, MD. Dr. Ismail, a highly ...

Assessing right ventricular diastolic function is crucial in cardiac surgery, as it significantly impacts long-term prognosis. Typically, RV diastolic dysfunction is evaluated using criteria ...

A new community diagnostics centre (CDC) is now fully operational. The facility at Southlands Hospital in Shoreham, featuring “world-class” CT and MRI scanners and three “cutting-edge” X-ray rooms, ...

Dr. Shelby Kutty, the Helen Taussig Professor and Director of Pediatric & Cardiology at Johns Hopkins School of Medicine delivered the presentation "How to handle incidental findings and unusual ...

Verdence Capital Advisors LLC lowered its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 23.3% in the ...

HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

The implantation is done under conscious sedation with no need for echocardiography (cardiac imaging) or general anesthesia.

It has already welcomed more than 60,000 patients since then. The recent opening of phase two means that the game-changing ...

Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...